InventisBio Co., Ltd. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported net loss was CNY 483.51 million compared to CNY 357.91 million a year ago. Basic loss per share from continuing operations was CNY 0.95 compared to CNY 0.78 a year ago.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.03 CNY | +2.03% | -7.81% | -46.96% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-46.96% | 639M | |
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.21B | |
+3.23% | 22.78B | |
-10.44% | 17.96B | |
-41.74% | 16.43B | |
-13.31% | 16.37B | |
+2.44% | 13.58B | |
+27.89% | 11.66B |
- Stock Market
- Equities
- 688382 Stock
- News InventisBio Co., Limited
- InventisBio Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022